Swiss National Bank’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Swiss National Bank’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-316,000	Closed	-$799K	–	2555
2023 Q4	$799K	Sell	316,000 -31,700	-9%	-$73.8K	﹤0.01%	2356
2023 Q3	$831K	Hold	347,700	–	–	﹤0.01%	2342
2023 Q2	$803K	Buy	347,700 +44,200	+15%	+$125K	﹤0.01%	2406
2023 Q1	$774K	Sell	303,500 -28,700	-9%	-$82.2K	﹤0.01%	2382
2022 Q4	$834K	Buy	332,200 +10,500	+3%	+$29.3K	﹤0.01%	2430
2022 Q3	$933K	Hold	321,700	–	–	﹤0.01%	2374
2022 Q2	$1.45M	Buy	+321,700	New	+$1.91M	﹤0.01%	2136

Swiss National Bank's SLGC Position: Q1 2024 in Review

Swiss National Bank sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 316,000 shares — an estimated $799K sold.

Swiss National Bank first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $1.45M in Q2 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Swiss National Bank reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Swiss National Bank sold 316,000 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $799K.
Swiss National Bank first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
Swiss National Bank's SomaLogic, Inc. Class A Common Stock position peaked at $1.45M in Q2 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Swiss National Bank's 13F filing for Q1 2024, filed 7 May 2024.